Background: Transfusion of blood at the limits of approved storage time is associated with lower red blood cell (RBC) post-transfusion recovery and hemolysis, which increases plasma cell-free hemoglobin and iron, proposed to induce endothelial dysfunction and impair host defense. There is noted variability among donors in the intrinsic rate of storage changes and RBC post-transfusion recovery, yet genetic determinants that modulate this process are unclear. Methods: We explore RBC storage stability and post-transfusion recovery in murine models of allogeneic and xenogeneic transfusion using blood from humanized transgenic sickle cell hemizygous mice (Hba tm1Paz Hbbtm1Tow
, Tamir 
Introduction
Sickle cell trait is the carrier status of sickle cell disease (SCD), a severe hemolytic disease that is caused by a point mutation in the gene encoding beta-hemoglobin (β6Glu → Val) that increases the hydrophobicity of this protein when deoxygenated. In SCD RBCs, this mutation causes Hb polymerization under small reductions in physiologic oxygen saturation leading to cell dehydration, increased membrane rigidity and hemolysis (Rees et al., 2010; Brittenham et al., 1985) . These altered red cell properties promote vaso-occlusive events in microcirculation, causing severe pain and end-organ ischemia, infarction and progressive dysfunction. Red blood cells (RBCs) from individuals with sickle cell trait (SCT) contain 25-50% HbS that polymerizes only at low fractional oxygen saturations b50% (Brittenham et al., 1985) . Thus, under normal physiologic conditions, individuals with sickle cell trait are asymptomatic. However, under extreme conditions of hypoxia and dehydration, vaso-occlusive events can occur (Statius van Eps and De Jong, 1997) .
Historically, donor RBC genetic background is considered benign if the donor lacks clinically relevant symptoms but prolonged storage exposes RBCs to non-physiologic stress conditions and may amplify the effects of occult mutations (Dern et al., 1967; Latham et al., 1982) .
Sickle cell trait has a high prevalence in malaria endemic regions, which increases the probability that patients requiring RBC transfusions in these regions will receive stored HbAS RBCs. Current transfusion practices supporting the use of sickle cell trait RBCs are based on limited studies performed decades ago, which reported no differences in posttransfusion survival or recovery of sickle trait RBCs compared with normal RBCs. However, storage duration was relatively short (b21 days compared with present 42-day storage limits) and utilized less sensitive methods to evaluate RBC post-transfusion survival (Callender et al., 1949; Ray et al., 1959; Levin and Truax, 1960) . Here, we show that sickle cell trait increases storage hemolysis and reduces red cell post-transfusion survival in mice, an effect that increases with increasing time in storage. Interestingly, transfused HbAS RBCs do not exhibit higher intravascular hemolysis compared to HbAA RBCs, but rather become entrapped in the systemic microcirculation. These findings raise concerns about the viability of stored sickle cell trait red blood cells after prolonged storage and suggest a need for further clinical evaluation of post-transfusion recovery of stored human HbAS containing RBCs.
Materials and Methods

Mice
8-12 week old wildtype (HbAA) mice (C57BL/6J), Berkeley hemizygous (HbAS) (Hba tm1Paz Hbb tm1Tow Tg(HBA-HBBs)41Paz/J) mice and transgenic mice expressing enhanced Green Fluorescent Protein in hematopoietic cells (C57BL/6-Tg(UBC-GFP)30Scha/J) were purchased from Jackson Laboratories. Berkeley hemizygous mice express human α-globin and sickle β-globin genes in addition to one copy of the murine β-globin, making them hemizygous for Sickle Cell Disease (HbAS). Our characterization studies and those of others suggest these mice express 20-30% HbS, which is similar to the 20-45% HbS distribution observed in sickle cell trait individuals (Noguchi et al., 2001; Steinberg and Embury, 1986) . Procedures involving animals were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. Both male and female mice were used as donors for RBC isolation. Recipient male mice were of C57Bl/6J strain and randomly assigned to experimental groups to receive either HbAA or HbAS blood. Experimenters performing the experiments was not blinded to group assignment but was blinded to outcome assessment. There was no exclusion of data from any animals.
Blood Collection and Storage
Leukoreduced human RBC units were stored under standard blood banking conditions from sickle cell trait donors and ABO blood type matched donors were obtained from Central Blood Bank (Pittsburgh, PA) and stored at 1-6°C until specified times for testing. Whole blood (WB) was collected from mice via the inferior vena cava immediately following euthanasia using Citrate Phosphate Dextrose solution as an anti-coagulant (Sigma St. Louis, MO). Pooled WB from mice and human blood was leukoreduced using a Pall Purecell® NEO Neonatal High Efficiency Leukocyte Reduction Filter (Hod et al., 2010b) . Leukoreduced blood was re-suspended in 14% CPDA-1 (Sigma St. Louis, MO), concentrated to a final hematocrit of 55%, and stored at 1-6°C in glass vacutainers shielded from light for up to 11 days (Hod et al., 2010b) .
In Vitro Hemolytic Assays
Storage hemolysis and stress-induced osmotic or mechanical hemolysis were measured by supernatant cell-free hemoglobin using Drabkin's assay (Moore et al., 1995) . See Supplemental section.
Post-Transfusion Survival Studies
Fresh or 11-day stored murine RBCs (equivalent to 39-42 day stored human RBCs) (Mangalmurti et al., 2009; Gilson et al., 2009 ) for transfusion were labeled with lipophilic dyes 1,1′-dioctadecyl-3,3,3′3′-tetramethylindocarbocyanine perchlorate dyes DiI (D-383) or DiD (D-307) (Invitrogen, Carlsbad CA) prior to infusion in recipient mice by retro-orbital injection. RBC 24 h post-transfusion recovery was obtained by blood sampling via tail vein and enumerated by flow cytometry and analyzed using FlowJo (Ashland, OR). To confirm that fluorescent labeling dyes do not alter RBC post-transfusion survival, C57BL/6 mice expressing Green Fluorescent Protein (GFP) driven by the human ubiquitin C promoter (C57BL/6-Tg (UBC-GFP) 30Scha/J) were transfused with unlabeled fresh or stored HbAA and HbAS RBCs individually and analyzed using a negative FITC gate to quantify 24 h post-transfusion recovery.
Statistical Methods
To measure storage-related changes between HbAA and HbAS RBCs such as echinocyte formation, changes in hemolytic propensity and post-transfusion survival, two-way ANOVA with Bonferroni post-test for individual comparisons was used to perform statistical analysis. To determine differences in HbAA and HbAS RBC sequestration in tissues, Mann-Whitney U test was used for non-parametric analysis (GraphPad Prism 6, La Jolla, CA). Initial pilot studies examining RBC post-transfusion recovery provided the basis for sample size estimation of recipient mice. Details regarding statistics, technical and biological replicates performed are provided in the Figure Legends 
Results
HbAS Red Blood Cells Exhibit Higher Storage Hemolysis, Increased Resistance to Osmotic Stress
To assess the membrane properties of HbAA and HbAS RBCs, conventionally banked human and murine RBCs stored in standard preservative solution were assayed at the beginning and end of storage. Human RBCs under standard blood banking can be stored up to 42 days (Koch et al., 2008) . Leukoreduced murine RBCs stored for up to 14 days show post-transfusion recovery that approximates what is observed with human RBCs at the limits of approved storage, suggesting that these shorter storage times represent a more appropriate and conservative model for day 39-42 human RBC storage (Hod et al., 2010b; Gilson et al., 2009) . By 39-42 days of storage, conventionally banked human HbAS (h-HbAS) RBCs exhibited higher storage hemolysis compared to human HbAA (h-HbAA) RBC samples (1.0 ± 0.6% versus 0.15 ± 0.02%, p = 0.0035, Fig. 1a ). RBCs from Berkeley hemizygous mice (m-HbAS) also exhibited higher storage hemolysis at the end of 11-day storage compared to murine HbAA (m-HbAA) RBCs (2.4 ± 0.16% versus 1.7 ± 0.1%, p = 0.0022, Fig. 1b) . In both human and murine HbAS RBCs, free hemoglobin concentrations were higher at the beginning of storage compared to HbAA RBCs, a transient increase likely due to mechanical challenges suffered during leukoreduction (Fig. 1a-b) (Stroncek et al., 2002) . The size distribution and hemoglobin content of human HbAA and HbAS RBCs showed no differences (Supplemental Fig. S1 ).
To determine membrane resilience to osmotic shock, packed RBCs were re-suspended in a hypotonic buffer for 3 h. Similar to prior findings in HbSS RBCs, (Franco et al., 2000) (Fig. 1e-f ). Taken together, the Berkeley murine HbAS RBCs appear to show similar membrane properties to that of human HbAS RBCs during storage, suggesting that these mice serve as a suitable model of sickle cell trait for transfusion studies.
Elevated Echinocyte Formation in HbAS RBCs Compared to HbAA RBCs During Storage
Echinocyte formation occurs due to various factors such as cell dehydration and ATP depletion, and has previously been used as a surrogate marker for RBC storage integrity (Flatt et al., 2014) . Human and murine RBCs were examined by scanning electron microscopy at the beginning and end of 39-42 or 11-day storage, respectively. There were no differ- 
Stored HbAS RBCs Exhibit Accelerated 24 h Post-Transfusion Clearance Compared to Stored HbAA RBCs
Next we sought to examine whether the increased storage hemolysis and increased echinocyte formation of human and mouse HbAS RBCs was indicative of accelerated aging that impacts post-transfusion survival. We established a murine model of allogeneic and xenogeneic transfusion, using transfusion of DiI-labeled and DiD-labeled donor RBCs (Hod et al., 2010b , Gilson et al., 2009 , Hod et al., 2010a . There was no significant difference in the post-transfusion recovery of fresh DiI-labeled h-HbAA and fresh DiD-labeled h-HbAS RBCs in mice at 24 h (Fig. 3a) . Fresh h-HbAA and h-HbAS showed 100% and 78.9% survival in circulation 24 h post-transfusion, respectively. The N 100% post-transfusion survival of fresh HbAA RBCs at earlier time points is due to incomplete distribution of transfused RBCs in the circulating blood volume at the time of the initial tail vein blood sampling (T i = 5 min post-transfusion). As T i is arbitrarily defined as 100% and all subsequent time points are referenced to Ti, fresh HbAA transfused RBCs, upon complete distribution, creates an artifact of N 100% survival in subsequent RBC recovery estimations given their negligible loss in circulation. This artifact has been previously reported in red cell survival post-transfusion studies (Franco et al., 2000 , Mock et al., 1999 . After 39-42 day storage, the mean 24 h post-transfusion survival was 71.6 ± 19.5% for stored h-HbAA and 4.3 ± 4.9% for stored h-HbAS RBCs (Fig. 3b) . Consistent with human RBCs, stored m-HbAS RBCs showed accelerated clearance from circulation compared with stored m-HbAA RBCs, whereas no differences were noted in post-transfusion recovery of fresh m-HbAS and fresh m-HbAA RBCs (Fig. 3c-d) .
The high 24 h post-transfusion survival of fresh human and murine HbAA or HbAS in recipient mice underscore the lack of an immunemediated clearance of transfused RBCs. The findings confirm previous reports indicating the absence of anti-major histocompatibility complex antibodies responsible for the clearance of incompatible red cells in mice, and suggest that the rapid clearance of human and murine HbAS RBCs is due to storage-dependent changes and not alloantibodymediated RBC clearance (Stimpfling et al., 1976; Hod et al., 2010a; Ong and Mattes, 1989) (Rice and Crowson, 1950) . To ensure that labeling dyes did not significantly impact RBC clearance, C57BL/B6 mice expressing GFP were transfused with unlabeled m-HbAA or m-HbAS RBCs (Supplemental Fig. S3 ). No differences were observed in the post-transfusion survival when fresh unlabeled m-HbAA and m-HbAS RBCs were transfused into separate groups of mice expressing GFP (Supplemental Figs. S3C, S4 ), while we again observed that the transfusion of unlabeled stored and aged m-HbAS RBCs showed accelerated clearance compared to unlabeled stored and aged m-HbAA RBCs (Supplemental Fig. S3D ).
Furthermore, there was no difference in the post-transfusion survival of stored human RBCs following 39-41 day storage in standard plasticizer bags or in glass (Supplemental Fig. S5 ) suggesting that HbAS RBC in vivo behavior following storage was not due to specific storage conditions. The post-transfusion clearance of stored human and murine RBCs show a bi-phasic curve with rapid disappearance of both HbAA and HbAS RBCs within 2 h post-transfusion, followed by slower rate of disappearance where HbAS RBCs exhibited two-fold rate of disappearance (rate of disappearance per hour, h-HbAS: 31.8% and h-HbAA: 12.6%; p = 0.0043) (Fig. 3b) and (m-HbAS: 24.5% versus m-HbAA RBC 13.8% p = 0.0022) at 2 h (Fig. 3d) . (Fig. 4a, b) . We show clodronate depletion of macrophages enhances early post-transfusion survival of stored m-HbAA RBCs as previously shown but not stored m-HbAS RBCs (Fig. 4c-d, S6A -B) (Hod et al., 2010b) . We next performed surgical splenectomies and survived mice for 5 days until stable for transfusion studies, we found that consistent with the RBC post-transfusion survival studies in splenectomized mice (Fig. 4d) , splenectomy did not alter tissue sequestration of stored m-HbAS RBCs within the kidneys and livers following transfusion ( Fig. 5a-b) . Taken together, these findings suggest that the mechanism of reduced post-transfusion survival of stored m-HbAS RBCs is different from that of stored m-HbAA RBCs where macrophageand spleen-mediated clearance mechanisms may play a predominant role. We further investigated whether intravascular hemolysis contributes to the reduced post-transfusion recovery of stored m-HbAS RBCs. Transfused mice recipients were assayed for plasma and urinary free hemoglobin at various time intervals. Recipient mice transfused with stored m-HbAS RBCs did not show higher levels of plasma or urinary free hemoglobin levels at 5 min and 4 h post-transfusion compared with mouse recipients transfused with m-HbAA RBCs (Supplemental Fig. S7 ), indicating that intravascular hemolysis did not contribute significantly to the reduced post-transfusion recovery of m-HbAS RBCs.
Increased Sequestration of Stored HbAS RBCs Within Kidney, Liver and Spleen Following Transfusion
To evaluate whether stored HbAS and HbAA RBC show differences in tissue entrapment following transfusion and provide an explanation for the rapid clearance of stored m-HbAS RBCs in intact WT recipient mice, we transfused cy3-labeled stored m-HbAA or m-HbAS RBCs and harvested kidney, liver and spleen of recipient mice 2 h post-transfusion for confocal imaging and quantitative analysis (Figs. 6 and 7) . There was higher sequestration of stored m-HbAS RBCs within the recipient kidney, liver and spleen when compared to recipients transfused with m-HbAA RBCs (Fig. 6a and b) . When stored h-HbAS and h-HbAA RBCs were transfused into murine recipients, h-HbAS RBCs were entrapped in the spleen to a greater extent than h-HbAA RBCs (Fig. 7a-b) , presumably due to the narrower internal diameter of splenic sinusoidal vessels (Schroit et al., 1984; Mebius and Kraal, 2005; Connor et al., 1994) . Collectively, these findings indicate that enhanced mechanical entrapment in tissue accounts for the rapid clearance of transfused HbAS RBCs from circulation of intact mice. It remains unclear why splenectomy did not improve RBC recovery in the circulation since this appears to be a major site of RBC entrapment. This may reflect the propensity of HbAS RBCs to entrap in the liver, kidney and other organs (Fig. 6a-b) .
Discussion
The main findings of this study are that both human and murine HbAS RBCs show accelerated storage-related aging and reduced posttransfusion survival after prolonged cold storage compared to HbAA RBCs. There was no difference in the post-transfusion recovery of fresh murine and human HbAA and HbAS RBCs when transfused into wild type C57Bl/6 mouse recipients, suggesting accelerated storageinduced aging of HbAS RBCs. Our findings indicate that enhanced mechanical entrapment in the kidney, liver and spleen account for the rapid clearance of stored m-HbAS RBCs following transfusion, an observation possibly consistent with rare clinical observations of organ injury in sickle cell trait individuals (Rice and Crowson, 1950) .
To date, over 1000 mutations in the human genome relate to the evolved response to endemic malaria infection, with sickle cell trait being one of the most common mutations that confers protection against this endemic parasite (Hedrick, 2011; Jallow et al., 2009) . It still remains to be determined whether other hemoglobinopathies, carrier status of alpha thalassemia, and glucose-6-phospate dehydrogenase (G6PD) deficiency that occur with high frequency in African Americans and populations originally from malaria endemic regions, exhibit similar behavior as sickle cell trait during storage and following transfusion. This is particularly important because these populations represent a donor pool from which sickle cell disease patients are likely to be transfused to reduce the risk of RBC allo-immunization. Carriers of these mutations usually do not present with clinical symptoms, however, as shown in this study, prolonged exposure of RBCs to storage-induced stress may unmask subtle perturbations of the heterozygous state.
Our data support previous studies showing no difference in the storage hemolysis of h-HbAA and h-HbAS RBCs at earlier time-points (up to 21 days) (Levin and Truax, 1960; Ray et al., 1959) . However, after 28 days, this accumulation intensifies in h-HbAS RBC units. These studies suggest a need to re-evaluate the suitability of HbAS RBCs for transfusion after prolonged storage since prior studies only examined RBCs that were stored for shorter periods (b21 days) of time in ACD anticoagulant and utilized less precise methods to assess RBC post-transfusion survival. In this controlled study, we utilize highly sensitive tracking methods in examining the storage integrity and post-transfusion survival of h-HbAS RBCs at the limits of the current approved storage time of 42 days. The relevance of this study is underscored by the observation that fresh h-HbAA and h-HbAS RBCs exhibit a high post-transfusion survival and only show decreased post-transfusion survival in wild type C57Bl/6 mice following storage, which cannot be explained by mechanical restraints due to the larger diameter of human RBCs compared to murine RBCs, since even stored h-HbAA RBCs still exhibit high posttransfusion survival.
There are no comprehensive studies evaluating clearance of human RBCs in immunocompetent mice. Prior studies utilized NOD-scid mice for xenotransfusion of human RBCs based upon an assumption that xenotransfusion in immunocompetent mice would induce rapid immune-mediated clearance of human RBCs (Bazin et al., 2002; Moore et al., 1995) . However, even in NOD-scid mice, fresh human RBCs showed significant clearance over the first 4 h, arguing against clearance by cross-reactive anti-hRBC antibodies as NOD-scid mice lack such antibodies (Moore et al., 1995; Bazin et al., 2002) . It is also unlikely that cross-species differences in RBCs induce rapid alternative complement-mediated lysis of h-RBC in mice, as mouse complement fails to lyse human RBCs (Ish et al., 1993) . In contrast, we observe near 100% post-transfusion recovery of fresh human AA RBCs transfused into immunocompetent C57Bl/6 mice. This discrepancy may be related to differences in the labeling method of transfused RBCs, as prior studies utilized chromium-labeling as an in vivo tracking method (Bazin et al., 2002) . Chromium binds to hemoglobin but it is possible that chromium may elute from transfused human hemoglobin and result in the artefactual appearance of rapid RBC clearance (Awwad et al., 1966; Gimlette, 1978) . We utilized a lipophilic fluorescent dye that directly intercalates with the RBC membrane.
To prevent the negative impact of hemolysis, the U.S. Food and Drug Administration set the upper threshold of hemolysis in a RBC unit to be transfused at 1% but some RBC units stored under standard blood banking conditions fail to meet this requirement due to factors that may be donor specific (Mishler et al., 1979; Dumont and AuBuchon, 2008) . The human HbAS RBCs purchased from a commercial blood bank for this study would not have met the regulatory requirement near the end of the FDA accepted shelf-life of 42 days, as these units exhibited a hemolysis level of N 1%. Other occult genetic mutations such as sickle cell trait that increase storage hemolysis may explain why some RBCs age faster during storage.
The enhanced tissue sequestration of HbAS RBCs that we observed may be due to reduced deformability of HbAS RBC membrane that worsens during storage and increases the propensity for microvascular obstruction. However, splenectomy of recipient mice did not alter posttransfusion recovery of stored m-HbAS RBC. This observation is likely due to the fact that the liver is significantly larger and about ten times the spleen weight in mice, so that increases in circulating RBCs after splenectomy are not measurable (Sisto et al., 2003) . The limitation in our technique to fully quantify the capacity of the liver to entrap and clear large numbers of stored RBCs in real time may account for the lack of observable differences.
One limitation of this study and previous studies utilizing murine RBCs to study the effect of storage lesion on RBC post-transfusion survival is the number of mice that are needed to obtain sufficient volumes (~75 ml) for conventional storage in pediatric transfer bags with diethylhexyl phthalate (DEHP). It has also been shown that storage in pediatric transfer bags increases RBC hemolysis and alters osmotic fragility (Kanias et al., 2013 ). These considerations demonstrate the practical challenges of an acceptable storage model to mimic RBC behavior in standard-sized blood bags. Of note, studies performed decades ago to determine the transfusion suitability of stored h-HbAS RBCs were not under current approved conditions (Levin and Truax, 1960; Ray et al., 1959) post-transfusion survival following 14-day storage as well as phosphatidylserine externalization and reduced CD47 expression similar to trends observed in human RBCs at the end of 42-day storage (Gilson et al., 2009 ).
In conclusion, HbAS RBCs harbor subtle differences in membrane resistance to osmotic stress, show accelerated degradation during prolonged storage, and reduced survival in circulation following transfusion. It remains unknown whether our findings of impaired transfusion recovery of both murine and human HbAS in mice reflect that of stored human HbAS red cells in humans. Nevertheless, these findings suggest that further investigation should be performed to determine a shorter length of allowable storage to improve the efficacy of stored HbAS RBCs and post-transfusion recovery in humans.
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